Search

everythinglearnresearchcommunity

for

Search:↓

LTBP1 is a key regulator in diseases and a potential target for new treatments.

PADI4 enzyme slows down cell growth in developing hair follicles.

Agouti and AGRP affect pigmentation and obesity, with implications for metabolic disorders.

Analog 23 is a promising compound for prostate cancer treatment.

Cholesterol issues in skin and hair may cause permanent hair loss by triggering inflammation.

Lower adiponectin levels are linked to higher insulin resistance in women with PCOS.

Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.

Cedrol promotes hair growth better than baricitinib by regulating immune cells.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Retinoic acid production and signaling in hair follicles are regulated by location and timing, affecting hair growth and cycling.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Decanoic acid may help treat PCOS by reducing androgen levels and improving glucose sensitivity.

Changes in the SREBF1 gene cause a rare genetic skin and hair disorder.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

Folliculin helps regulate energy and nutrient sensing, impacting Birt–Hogg–Dubé syndrome.

Keratin-associated proteins may have roles in various mouse tissues, not just hair.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

This enzyme helps metabolize fatty acids and isoleucine, and could be key in treating neurological diseases and certain cancers.